Mobile app version of munafa.biz
Login or Join
 Learn then Earn
stockMarketNEWS

 story : MorphoSys shares plunge after partner Roche says Alzheimer's drug trials didn't meet goals #FinanceUSA #StockMarketNEWS German-listed shares of MorphoSys lost a third of their value on Monday after

@stockMarketNEWS Tue 15 Nov, 2022

Posted in: #FinanceUSA #StockMarketNEWS

MorphoSys shares plunge after partner Roche says Alzheimer's drug trials didn't meet goals #FinanceUSA #StockMarketNEWS
German-listed shares of MorphoSys lost a third of their value on Monday after its partner Roche said an Alzheimer drug trial failed. Roche slumped 4% in Zurich as the company said Phase 3 studies evaluating gantenerumab in people with mild cognitive impairment (MCI) due to Alzheimer's and mild Alzheimer's dementia did not meet their primary endpoint of slowing clinical decline.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme